NSC |
Compound |
Enrichment |
Correlation |
NSC 747558 |
6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one |
0.0171439890681608 |
0.21074941 |
NSC 754109 |
ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate |
0.0171439890681608 |
0.18180437 |
NSC 754240 |
2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one |
0.0171439890681608 |
0.20306783 |
NSC 756134 |
GSK1023156A |
0.0171439890681608 |
0.23411008 |
NSC 762149 |
N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide |
0.0171439890681608 |
-0.14263931 |
NSC 93287 |
Null |
0.0171439890681608 |
0.19752219 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0181211508101519 |
0.20514744 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0181211508101519 |
0.24946346 |
NSC 237020 |
TA 1067 |
0.0181211508101519 |
0.31221981 |
NSC 335766 |
Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- |
0.0181211508101519 |
0.24466115 |